Literature DB >> 6434219

Propranolol interactions with diazepam, lorazepam, and alprazolam.

H R Ochs, D J Greenblatt, B Verburg-Ochs.   

Abstract

Healthy subjects received single doses of diazepam (5 to 10 mg iv), lorazepam (2 mg iv), or alprazolam (1 mg orally) on two occasions, once in the control state and once with propranolol, 80 mg three times a day. Compliance with the propranolol regimen was verified by measurement of serum propranolol levels (overall means: 100 ng/ml) and by reduction in sensitivity to intravenous metaproterenol to one-thirtieth that of the control value. Propranolol prolonged diazepam elimination t1/2 (58 and 49 hr), reduced its clearance (0.20 and 0.24 ml/min/kg), and increased the 168-hr AUC for desmethyldiazepam, the major metabolite of diazepam (5.63 and 4.81 micrograms/ml . hr). Propranolol had no significant effect on lorazepam t1/2 (13.2 and 12.7 hr) or clearance (1.33 and 1.36 ml/min/kg), nor on alprazolam t1/2 (15.9 and 18.5 hr) or clearance (1.1 and 0.8 ml/min/kg). Thus propranolol induces a small but significant reduction in clearance of diazepam, biotransformed mainly by the oxidative reaction of N-demethylation. Propranolol does not impair lorazepam clearance by glucuronide conjugation nor that of alprazolam by aliphatic hydroxylation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434219     DOI: 10.1038/clpt.1984.203

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

1.  Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin.

Authors:  H Y Pan; J Triscari; A R DeVault; S A Smith; D Wang-Iverson; B N Swanson; D A Willard
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

2.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.

Authors:  J Sonne; M Døssing; S Loft; K L Olesen; A Vollmer-Larsen; M A Victor; O Hamberg; H Thyssen
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Interaction of metoprolol with lorazepam and bromazepam.

Authors:  A K Scott; G A Cameron; G M Hawksworth
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

5.  Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate.

Authors:  H R Ochs; D J Greenblatt; A Locniskar; J Weinbrenner
Journal:  Klin Wochenschr       Date:  1986-12-01

Review 6.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 7.  Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice.

Authors:  Lisa J Heaton; Daniel W McNeil; Peter Milgrom
Journal:  SAAD Dig       Date:  2010-01

8.  Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.

Authors:  J O Miners; L M Wing; K J Lillywhite; R A Robson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

9.  Propranolol does not alter flutoprazepam kinetics and metabolism in the rat.

Authors:  I Conti; S Sarati; S Caccia
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

10.  The effect of propranolol on paracetamol metabolism in man.

Authors:  O Z Baraka; C A Truman; J M Ford; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.